Cargando…

Readily accessible risk model to predict in-hospital major adverse cardiac events in patients with acute myocardial infarction: a retrospective study of Chinese patients

OBJECTIVE: Rapid, accurate identification of patients with acute myocardial infarction (AMI) at high risk of in-hospital major adverse cardiac events (MACE) is critical for risk stratification and prompt management. This study aimed to develop a simple, accessible tool for predicting in-hospital MAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xiaoxia, Du, Xin, Wang, Guohong, Zhao, Xiaoyan, Zheng, Yang, Li, Yingxue, Xia, Eryu, Qin, Yong, Dong, Jianzeng, Ma, Chang-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Medical Management
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252882/ https://www.ncbi.nlm.nih.gov/pubmed/34210722 http://dx.doi.org/10.1136/bmjopen-2020-044518

Ejemplares similares

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Characterisations of adverse events detected in a university hospital: a 4-year study using the Global Trigger Tool method
por: Rutberg, Hans, et al.
Publicado: (2014)

Development and evaluation of a data-driven integrated management app for perioperative adverse events: protocol for a mixed-design study
por: Li, Peiyi, et al.
Publicado: (2023)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Readily accessible multifunctional fluorous emulsions
por: Sletten, Ellen M., et al.
Publicado: (2016)

Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction
por: Shon, Ho Sun, et al.
Publicado: (2017)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Long-term Predictive Factors of Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Bae, Eun Hui, et al.
Publicado: (2005)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
por: Sardu, Celestino, et al.
Publicado: (2019)

High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients
por: Sumarjaya, I Dewa Gde Dwi, et al.
Publicado: (2020)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
por: Chai, Qiaoying, et al.
Publicado: (2023)

High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction
por: Xu, Qiyao, et al.
Publicado: (2017)

In-hospital and 30-day major adverse cardiac events in patients referred for ST-segment elevation myocardial infarction in Dhaka, Bangladesh
por: Akhtar, Zubair, et al.
Publicado: (2021)

Readily accessible CT scoring method to quantify fibrosis in IPF
por: Fraser, Emily, et al.
Publicado: (2020)

Generating Multibillion Chemical Space of Readily Accessible Screening Compounds
por: Grygorenko, Oleksandr O., et al.
Publicado: (2020)

Generating Multibillion Chemical Space of Readily Accessible Screening Compounds
por: Grygorenko, Oleksandr O., et al.
Publicado: (2020)

Value of ATRIA risk score and gender in predicting adverse events in patients with myocardial infarction
por: Öncel, Can Ramazan
Publicado: (2018)

Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
por: Sato, Jun, et al.
Publicado: (2023)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction
por: Wang, Qian, et al.
Publicado: (2017)

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention
por: Pan, Defeng, et al.
Publicado: (2021)

Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction
por: Guo, Wen, et al.
Publicado: (2023)

Cardiovascular magnetic resonance-derived left atrioventricular coupling index and major adverse cardiac events in patients following acute myocardial infarction
por: Lange, Torben, et al.
Publicado: (2023)

Association of platelet-to-lymphocyte count ratio with myocardial reperfusion and major adverse events in patients with acute myocardial infarction: a two-centre retrospective cohort study
por: Maimaiti, Ailifeire, et al.
Publicado: (2019)

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
por: Mendonça, Maria Isabel, et al.
Publicado: (2021)

Myocardial Injury Is Associated with the Incidence of Major Adverse Cardiac Events in Patients with Severe Trauma
por: Stroda, Alexandra, et al.
Publicado: (2022)

Unsatisfactory Management of Patients with Myocardial Infarction Admitted to General Medical Wards
por: Lawson-Matthew, P J, et al.
Publicado: (1994)

Association between Low Serum Magnesium Level and Major Adverse Cardiac Events in Patients Treated with Drug-Eluting Stents for Acute Myocardial Infarction
por: An, Guipeng, et al.
Publicado: (2014)

Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction
por: Kim, Min, et al.
Publicado: (2021)

Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease
por: Winter, Lauren, et al.
Publicado: (2018)

Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
por: Su, Gong, et al.
Publicado: (2013)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
por: Shang, Pu, et al.
Publicado: (2019)

Circulating Platelet-Derived Microparticles Associated with Postdischarge Major Adverse Cardiac Events in ST-Elevation Acute Myocardial Infarction
por: Hartopo, Anggoro Budi, et al.
Publicado: (2020)

Prediction models for major adverse cardiovascular events following ST-segment elevation myocardial infarction and subgroup-specific performance
por: Chen, Weiyao, et al.
Publicado: (2023)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
por: Silverio, Angelo, et al.
Publicado: (2022)

Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
por: Yildiz, Mehmet, et al.
Publicado: (2023)

Interventions to reduce post-traumatic stress disorder symptoms in health care professionals from 2011 to 2021: a scoping review
por: Qian, Jialu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tapfvll9l1lj1va0i1lb0dsmi2